EDGAR Filing Documents for 0001654954-17-002190

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001654954-17-002190

Filing Date

2017-03-21

Accepted

2017-03-20 17:31:11

Documents

Period of Report

2017-03-20

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	form6-k_proxy.htm	6-K	19931
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	33300
3	EXHIBIT 99.2	ex992.htm	EX-99.2	528197
4	EXHIBIT 99.3	ex993.htm	EX-99.3	10461
5	EXHIBIT 99.4	ex994.htm	EX-99.4	4331
6	EXHIBIT 99.5	exh_995.htm	EX-99.5	14369
7	IMAGE	csthdr.jpg	GRAPHIC	8935
8	IMAGE	cstlogo.jpg	GRAPHIC	6451
9	IMAGE	ex994000000.jpg	GRAPHIC	144810
10	IMAGE	ex994000001.jpg	GRAPHIC	69077
11	IMAGE	ex994000002.jpg	GRAPHIC	147497
12	IMAGE	ex994000003.jpg	GRAPHIC	81878
13	IMAGE	intellipharmaceutics_logo.jpg	GRAPHIC	7239
14	IMAGE	letter-deloitte000.jpg	GRAPHIC	57856
15	IMAGE	letter-mnp000.jpg	GRAPHIC	72944
16	IMAGE	performancegraph.jpg	GRAPHIC	56219
	Complete submission text file	0001654954-17-002190.txt		1512136

Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2

Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001

Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)